Shuyin Xinke completes Pre-A funding round, led by JBP Bio

Funding Rounds

▤ Summary

Shanghai Shuyin Xinke completed a Pre-A funding round at the end of May 2026. The round was led by JBP Bio and included investors from CMB International Capital, Lingang Digital Science Fund, Minjin Investment, and Kangrong Pharmaceutical. The company uses artificial intelligence for drug discovery and plans to use the new capital to upgrade its AI drug R&D platform, advance core programs, and expand its team. The funding move suggests the company is entering a faster preclinical development phase.

$ Funding

$
Amount - Total raised
□
Date June 2, 2026 Announcement date
◎
Investors - Lead investors
▥
Company https://www.digitalgeneai.tech/ Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies